Background. IgA nephropathy (IgAN) is characterized by deposition of p
olymers of IgA(1) in the mesangium, accumulation of mesangial matrix a
nd mesangial cell proliferation. Activation of the mesangial cell by I
gA, via an IgA receptor, may be an initiating event in the pathology o
f IgAN. Methods. We examined the ability of radiolabeled, normal serum
IgA(1) to bind human mesangial cells (HMC). Activation of HMC by mono
meric (mIgA(1))and heat aggregated IgA(1) (AIgA(1)) was compared by No
rthern analysis of c-jun expression. The expression of Fc alpha R1 (CD
89) mRNA on our cultured mesangial cells was also assessed by Northern
analysis, reverse transcription-polymerase chain reaction (RT-PCR) an
d flow cytometry. Results. I-125-mIgA(1) and I-125-AIgA(1) bound to HM
C in a dose-dependent, saturable manner with similar affinities. There
were 1.2 x 10(6) binding sites per cell, with an affinity constant of
2.3 x 10(6) M-1. AIgA(1) induced c-jun expression in a time and dose-
dependent manner (2.4-fold above baseline after 60 min exposure to AIg
A(1) 200 mu g/ml) while mIgA(1) had no effect on c-jun expression. No
message for CD 89 was detectable in quiescent or AIgA(1) stimulated HM
C by Northern analysis or RT-PCR using several primer sequences based
on the sequence of U937 Fc alpha R cDNA. Flow cytometry on the mesangi
al cells, using My 43, a monoclonal antibody to Fc alpha R1 confirmed
that CD 89 was not present on the cell. Conclusion. These results demo
nstrate that HMC bind mIgA(1) and AIgA(1) with similar affinity. Howev
er, activation of HMC requires an aggregated form of IgA(1). These pro
cesses are independent of Fc alpha R1, suggesting the presence of a ne
w IgA receptor on mesangial cells.